1. Home
  2. CADL vs NEWT Comparison

CADL vs NEWT Comparison

Compare CADL & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.04

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

HOLD

Current Price

$11.06

Market Cap

395.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
NEWT
Founded
1999
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
395.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
NEWT
Price
$5.04
$11.06
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
$19.00
$15.33
AVG Volume (30 Days)
1.2M
203.4K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
6.88%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.45
P/E Ratio
N/A
$5.99
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$9.12
52 Week High
$7.24
$14.91

Technical Indicators

Market Signals
Indicator
CADL
NEWT
Relative Strength Index (RSI) 49.25 39.44
Support Level $4.58 $10.28
Resistance Level $5.42 $11.38
Average True Range (ATR) 0.25 0.36
MACD 0.03 -0.00
Stochastic Oscillator 70.00 38.10

Price Performance

Historical Comparison
CADL
NEWT

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.

Share on Social Networks: